AVMA news
Unlawful xylazine receives more scrutiny to prevent inclusion in illegal drugs
Regulators and legislators are showing greater interest in xylazine, a prescription drug used in multiple sectors of clinical veterinary medicine,…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
AVMA CEO addresses workforce trends
Speaking to animal health industry leaders this August, AVMA CEO Dr. Janet Donlin talked about the challenges and opportunities facing the veterinary…
AVMA news
VCPR requirements fuel state legislative activity
The issue of whether to establish a veterinarian-client-patient-relationship (VCPR) through an in-person examination or solely electronic means has…
AVMA news
Raw pet food diets, pet population management policies headed to HOD
The AVMA House of Delegates, during its regular winter session, being held January 5-6, 2024, in Chicago, will vote on six resolutions that would…
AVMA news
HHS, senators request DEA reschedule marijuana
Legislators are seeking to remove marijuana from the Controlled Substances Act (CSA) after the U.S. Department of Health and Human Services (HHS)…
AVMA news
Bill seeks extension for new small business reporting requirement
As of January 1, small U.S. businesses are required to report ownership details to the U.S. Department of Treasury. However, legislators are seeking…